Evidence map›Paper›PMID 38202483›Full record

ReviewNanomaterials (Basel, Switzerland)2023

Perovskite Topological Lasers: A Brand New Combination.

Liangshen Wang, Lijie Wu, Yong Pan

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liangshen WangCollege of Science, Xi'an University of Architecture & Technology, Xi'an 710055, China.
Lijie WuCollege of Science, Xi'an University of Architecture & Technology, Xi'an 710055, China.ORCID 0009-0000-2238-8729
Yong PanCollege of Science, Xi'an University of Architecture & Technology, Xi'an 710055, China.ORCID 0000-0002-9647-8919

Funding

National Natural Science Foundation of China 62305262Natural Science Foundation of Shaanxi Province 2022JQ-652Shaanxi Fundamental Science Research Project for Mathematics and Physics 22JSQ026The project of talent introduction of Xi'an University of architecture and technology 1960320034
6 · The paper itself

Abstract

Nanolasers are the essential components of modern photonic chips due to their low power consumption, high energy efficiency and fast modulation. As nanotechnology has advanced, researchers have proposed a number of nanolasers operating at both wavelength and sub-wavelength scales for application as light sources in photonic chips. Despite the advances in chip technology, the quality of the optical cavity, the operating threshold and the mode of operation of the light source still limit its advanced development. Ensuring high-performance laser operation has become a challenge as device size has been significantly reduced. A potential solution to this problem is the emergence of a novel optical confinement mechanism using photonic topological insulator lasers. In addition, gain media materials with perovskite-like properties have shown great potential for lasers, a role that many other gain materials cannot fulfil. When combined with topological laser modes, perovskite materials offer new possibilities for the operation and emission mechanism of nanolasers. This study introduces the operating mechanism of topological lasers and the optical properties of perovskite materials. It then outlines the key features of their combination and discusses the principles, structures, applications and prospects of perovskite topological lasers, including the scientific hurdles they face. Finally, the future development of low-dimensional perovskite topological lasers is explored.

Indexed as

nanolaserperovskitephotonic chiptopological laser

Identifiers

PMID38202483
PMCPMC10781028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.